<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01228617</url>
  </required_header>
  <id_info>
    <org_study_id>A6431114-NICTDP1063</org_study_id>
    <nct_id>NCT01228617</nct_id>
  </id_info>
  <brief_title>Single-dose Pharmacokinetics of Oral Nicotine Replacement Products</brief_title>
  <official_title>Single-dose Pharmacokinetics of Oral Nicotine Replacement Products - An Exploratory Study in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Consumer and Personal Products Worldwide</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Consumer and Personal Products Worldwide</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an explorative study comparing new prototypes of Nicotine Replacement Products with
      Nicorette® gum.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study included 40 subjects who were randomly assigned to one of eight treatment
      sequences. In four of the sequences, the three prototypes with the shorter dissolution time
      and the reference were used; in the remaining four sequences, the three prototypes with the
      longer dissolution time and the reference were used. Hence, half of the subjects received the
      Short prototypes and half received the Long prototypes. Subjects in both treatment groups
      (short and long) attended four treatment visits, each of 11 hours' duration, and periods of
      at least 36 hours' duration between treatment visits.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum Concentration</measure>
    <time_frame>Baseline to 10 hours post-dose</time_frame>
    <description>The maximum observed nicotine concentration in plasma (Cmax)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the Curve</measure>
    <time_frame>10 hours post-dose</time_frame>
    <description>The area under the plasma concentration-vs.-time curve until the last measurable concentration (AUCt)and the area under the plasma concentration-vs.-time curve until infinity (AUC∞)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Maximum Concentration</measure>
    <time_frame>10 hours post-dose</time_frame>
    <description>Time to Maximum Concentration (Tmax)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual Nicotine</measure>
    <time_frame>30 minutes</time_frame>
    <description>The amount of residual nicotine in the product after being chewed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dissolution Time</measure>
    <time_frame>10 hours post-dose</time_frame>
    <description>Actual time required for oral dissolution of new NRT products following product administration</description>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Tobacco Dependence</condition>
  <arm_group>
    <arm_group_label>A1 Short, no buffer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine / not yet marketed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2 Short, low buffer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine / not yet marketed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A3 Short, high buffer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine / not yet marketed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B1 Long, no buffer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine / not yet marketed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B2 Long, low buffer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine / not yet marketed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B3 Long, high buffer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine / not yet marketed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>R = Nicotine Gum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nicorette® Gum</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine</intervention_name>
    <description>Following a 12-hour nicotine abstinence period, subjects receive a single 2 mg dose of their assigned nicotine replacement therapy in the morning of the treatment visit day</description>
    <arm_group_label>A1 Short, no buffer</arm_group_label>
    <arm_group_label>A2 Short, low buffer</arm_group_label>
    <arm_group_label>A3 Short, high buffer</arm_group_label>
    <arm_group_label>B1 Long, no buffer</arm_group_label>
    <arm_group_label>B2 Long, low buffer</arm_group_label>
    <arm_group_label>B3 Long, high buffer</arm_group_label>
    <other_name>Not yet marketed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Gum</intervention_name>
    <description>Following a 12-hour nicotine abstinence period, subjects will be instructed to chew the gum once every 2 seconds, for 30 minutes.</description>
    <arm_group_label>R = Nicotine Gum</arm_group_label>
    <other_name>Nicorette®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy smokers, smoking at least 10 cigarettes daily during at least one year
             preceding inclusion and BMI between 17.5 and 30.0 kg/m2.

          -  Female participants of child-bearing potential are required to use a medically
             acceptable means of birth control.

          -  A personally signed and dated informed consent document, indicating that the subject
             has been informed of all pertinent aspects of the study.

        Exclusion Criteria:

          -  Pregnancy, lactation or intended pregnancy.

          -  Treatment with an investigational product or donation or loss of blood within 3 month
             preceding the first dose of study medication.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth Kruse, PhD</last_name>
    <role>Study Director</role>
    <affiliation>McNeil AB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Trial Unit, Clinical Research and Trial Centre</name>
      <address>
        <city>Lund</city>
        <zip>SE-221 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2010</study_first_submitted>
  <study_first_submitted_qc>October 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2010</study_first_posted>
  <last_update_submitted>October 4, 2011</last_update_submitted>
  <last_update_submitted_qc>October 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Smoking Cessation</keyword>
  <keyword>Nicotine pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

